Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Johnson

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Nature Communications|December 8, 2018
Phase diagram of Bi<sub>2</sub>Sr<sub>2</sub>CaCu<sub>2</sub>O<sub>8+δ</sub> revisitedI K Drozdov, I Pletikosić, C-K Kim, et al.
Nature|June 7, 2002
Coherence incoherence and dimensional crossover in layered strongly correlated metalsT Valla, P D Johnson, Z Yusof, et al.
Journal of Medicinal Chemistry|April 1, 1994
Discovery, synthesis, and bioactivity of bis(heteroaryl)piperazines. 1. A novel class of non-nucleoside HIV-1 reverse transcriptase inhibitorsD L Romero, R A Morge, C Biles, et al.
Physical Review Letters|November 3, 2001
Doping and temperature dependence of the mass enhancement observed in the cuprate Bi(2)Sr(2)CaCu(2)O(8+delta)P D Johnson, T Valla, A V Fedorov, et al.
International Journal of Toxicology|January 5, 2002
Trichloroethylene, trichloroacetic acid, and dichloroacetic acid: do they affect fetal rat heart development?J W Fisher, S R Channel, J S Eggers, et al.
Physical Review Letters|April 20, 2004
Quasiparticle line shape of Sr2RuO4 and its relation to anisotropic transportS-C Wang, H-B Yang, A K P Sekharan, et al.
Nature Communications|December 21, 2016
Energy dissipation from a correlated system driven out of equilibriumJ D Rameau, S Freutel, A F Kemper, et al.
Journal of Medicinal Chemistry|August 28, 1998
Tipranavir (PNU-140690): a potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide classS R Turner, J W Strohbach, R A Tommasi, et al.
Journal of Medicinal Chemistry|November 8, 1996
Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitorsS Thaisrivongs, D L Romero, R A Tommasi, et al.
Journal of Medicinal Chemistry|March 28, 1997
Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramonesH I Skulnick, P D Johnson, P A Aristoff, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Nature Communications|December 8, 2018
Phase diagram of Bi<sub>2</sub>Sr<sub>2</sub>CaCu<sub>2</sub>O<sub>8+δ</sub> revisitedI K Drozdov, I Pletikosić, C-K Kim, et al.
Nature|June 7, 2002
Coherence incoherence and dimensional crossover in layered strongly correlated metalsT Valla, P D Johnson, Z Yusof, et al.
Journal of Medicinal Chemistry|April 1, 1994
Discovery, synthesis, and bioactivity of bis(heteroaryl)piperazines. 1. A novel class of non-nucleoside HIV-1 reverse transcriptase inhibitorsD L Romero, R A Morge, C Biles, et al.
Physical Review Letters|November 3, 2001
Doping and temperature dependence of the mass enhancement observed in the cuprate Bi(2)Sr(2)CaCu(2)O(8+delta)P D Johnson, T Valla, A V Fedorov, et al.
International Journal of Toxicology|January 5, 2002
Trichloroethylene, trichloroacetic acid, and dichloroacetic acid: do they affect fetal rat heart development?J W Fisher, S R Channel, J S Eggers, et al.
Physical Review Letters|April 20, 2004
Quasiparticle line shape of Sr2RuO4 and its relation to anisotropic transportS-C Wang, H-B Yang, A K P Sekharan, et al.
Nature Communications|December 21, 2016
Energy dissipation from a correlated system driven out of equilibriumJ D Rameau, S Freutel, A F Kemper, et al.
Journal of Medicinal Chemistry|August 28, 1998
Tipranavir (PNU-140690): a potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide classS R Turner, J W Strohbach, R A Tommasi, et al.
Journal of Medicinal Chemistry|November 8, 1996
Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitorsS Thaisrivongs, D L Romero, R A Tommasi, et al.
Journal of Medicinal Chemistry|March 28, 1997
Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramonesH I Skulnick, P D Johnson, P A Aristoff, et al.
Pageof 8